Systematic review of treatments for Stevens–Johnson syndrome and toxic epidermal necrolysis using the SCORTEN score as a tool for evaluating mortality

Therapeutic Advances in Drug Safety

Volumn 2, Issue 3, 2011, Pages 87-94

  Roujeau, Jean Claude ^a   Bastuji Garin, Sylvie ^b  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b HENRI MONDOR HOSPITAL   (France)

Author keywords

corticosteroids; intravenous immunoglobulins; Stevens Johnson syndrome; toxic epidermal necrolysis; treatment

Indexed keywords

EID: 84993661235     PISSN: 20420986     EISSN: 20420994     Source Type: Journal    
DOI: 10.1177/2042098611404094     Document Type: Article

References (27)

1. Bachot N. Revuz J. Roujeau J.-C. (2003) Intravenous immunoglobulin treatment for Stevens–Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression. Arch Dermatol 139: 33–36.
2. Bastuji-Garin S. Fouchard N. Bertocchi M. Revuz J. Roujeau J.-C. Wolkenstein P. (2000) SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol 115: 149–153.
3. Bastuji-Garin S. Rzany B. Stern R.S. Shear N.H. Naldi L. Roujeau J.-C. (1993) Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 129: 92–96.
4. Boorboor P. Vogt P.M. Bechara F.G. Alkandari Q. Aust M. Gohritz A. (2008) Toxic epidermal necrolysis: use of Biobrane or skin coverage reduces pain, improves mobilisation and decreases infection in elderly patients. Burns 34: 487–492.
5. Boussofara L. Maalaoui H. Mebazaa A. Ghariani N. Denguezli M. Belajouza C. (2007) Syndrome de Lyell, à propos de 16 cas. Tunis Med 85: 801–805.
6. Brown K.M. Silver G.M. Halerz M. Walaszek P. Sandroni A. Gamelli R.L. (2004) Toxic epidermal necrolysis: does immunoglobulin make a difference?. J Burn Care Rehabil 25: 81–88.
7. Campione E. Marulli G.C. Carrozzo A.M. Chimenti M.S. Costanzo A. Bianchi L. (2003) High-dose intravenous immunoglobulin for severe drug reactions: efficacy in toxic epidermal necrolysis. Acta Derm Venereol 83: 430–432.
8. Cartotto R. Mayich M. Nickerson D. Gomez M. (2008) SCORTEN accurately predicts mortality among toxic epidermal necrolysis patients treated in a burn center. J Burn Care Res 29: 141–146.
9. Chung W.H. Hung S.I. Yang J.Y. Su S.C. Huang S.P. Wei C.Y. (2008) Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat Med 14: 1343–1350.
10. Endorf F.W. Cancio L.C. Gibran N.S. (2008) Toxic epidermal necrolysis clinical guidelines. J Burn Care Res 29: 706–712.
11. Friedman H.Z. Arias A.M. Catchatourian R. Fretzin D.F. (1984) Toxic epidermal necrolysis following bone marrow transplantation. Cutis 34: 158–162.
12. Gerdts B. Vloemans A.F. Kreis R.W. (2007) Toxic epidermal necrolysis: 15 years– experience in a Dutch burns centre. J Eur Acad Dermatol Venereol 21: 781–788.
13. Guégan S. Bastuji-Garin S. Poszepczynska-Guigné E. Roujeau J.-C. Revuz J. (2006) Performance of the SCORTEN during the first five days of hospitalization to predict the prognosis of epidermal necrolysis. J Invest Dermatol 126: 272–276.
14. Imahara S.D. Holmes J.H. IV Heimbach D.M. Engrav L.E. Honari S. Klein M.B. (2006) SCORTEN overestimates mortality in the setting of a standardized treatment protocol. J Burn Care Res 27: 270–275.
15. Kardaun S.H. Jonkman M.F. (2007) Dexamethasone pulse therapy for Stevens–Johnson syndrome/toxic epidermal necrolysis. Acta Derm Venereol 87: 144–148.
16. Kim K.J. Lee D.P. Suh H.S. Lee M.W. Choi J.H. Moon K.C. (2005) Toxic epidermal necrolysis: analysis of clinical course and SCORTEN-based comparison of mortality rate and treatment modalities in Korean patients. Acta Derm Venereol 85: 497–502.
17. Mockenhaupt M. (2009) Severe drug-induced skin reactions: clinical pattern, diagnostics and therapy. J Dtsch Dermatol Ges 7: 142–160.
18. Nassif A. Bensussan A. Boumsell L. Deniaud A. Moslehi H. Wolkenstein P. (2004) Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells. J Allergy Clin Immunol 114: 1209–1215.
19. Palmieri T.L. Greenhalgh D.G. Saffle J.R. Spence R.J. Peck M.D. Jeng J.C. (2002) A multicenter review of toxic epidermal necrolysis treated in U.S. burn centers at the end of the twentieth century. J Burn Care Rehabil 23: 87–96.
20. Rzany B. Mockenhaupt M. Baur S. Schröder W. Stocker U. Mueller J. (1996) Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990–1992): structure and results of a population-based registry. J Clin Epidemiol 49: 769–773.
21. Samuels S.J. Beaumont J.J. Breslow N.E. (1991) Power and detectable risk of seven tests for standardized mortality ratios. Am J Epidemiol 133: 1191–1197.
22. Schneck J. Fagot J.P. Sekula P. Sassolas B. Roujeau J.-C. Mockenhaupt M. (2008) Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR Study. J Am Acad Dermatol 58: 33–40.
23. Stella M. Clemente A. Bollero D. Risso D. Dalmasso P. (2007) Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS): experience with high-dose intravenous immunoglobulins and topical conservative approach. A retrospective analysis. Burns 33: 452–459.
24. Trent J.T. Kirsner R.S. Romanelli P. Kerdel F.A. (2003) Analysis of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis using SCORTEN: the University of Miami Experience. Arch Dermatol 139: 39–43.
25. Viard I. Wehrli P. Bullani R. Schneider P. Holler N. Salomon D. (1998) Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 282: 490–493.
26. Wolkenstein P. Latarjet J. Roujeau J.-C. Duguet C. Boudeau S. Vaillant L. (1998) Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis. Lancet 352: 1586–1589.
27. Yang Y. Xu J. Li F. Zhu X. (2009) Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China. Int J Dermatol 48: 1122–1128.